Sean Ritchie is a Patent Attorney and member of the firm's Intellectual Property & Technology group. His practice focuses on intellectual property protection, including counseling clients on patent infringement, patentability, patent drafting, and patent prosecution. With an academic background in bioengineering, Sean's practice primarily focuses on chemical, life sciences, and materials science technologies. He also handles FDA compliance issues for medical devices.
Nashville Office Recruiting Committee, Member
Prior to joining Stites & Harbison in 2016, Sean was with McNees Wallace & Nurick LLC in Pennsylvania. Prior to that, he was in-house counsel for a biotechnology company where he focused on healthcare and medical device regulation. Sean is certified in neurophysiological introperative monitoring, and has spent time in the operating room monitoring somatosensory responses from patients during various vascular and neurological surgeries.
The patent process can be frustrating and often involves a significant investment of time and money. As such, it may be tempting to assume that when the Patent Office issues a patent it is safe to assert your rights therein. However, as noted in a recent decision from the District Court for the District of Delaware, doing so may leave you on the hook for attorney’s fees.
On January 7, 2019, the USPTO released updated guidance on how Patent Examiners should determine whether an invention is directed to subject matter that is eligible for patent protection under 35 U.S.C. § 101.
LOUISVILLE, Ky.—Stites & Harbison, PLLC announced today that five attorneys have been promoted within the law firm effective January 2019.
There are several different kinds of intellectual property protection (e.g., trademarks, patents, and copyrights). The borders between the types of protection are not always clear, and it may be that some subject matter is eligible for protection in more than one category.